Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics. - Wikidata - awgldk - TriplyDB

Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.

Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.

http://www.wikidata.org/entity/Q33687329

about

Significance of prohibitin domain family in tumorigenesis and its implication in cancer diagnosis and treatment.

P2860

Q55253157-8780265B-7356-432D-BF73-771AD575219E

P2860

Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.

http://www.wikidata.org/entity/Q33687329

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Stapled BIG3 helical peptide E ...... or breast cancer therapeutics.

@ast

Stapled BIG3 helical peptide E ...... or breast cancer therapeutics.

@en

type

label

Stapled BIG3 helical peptide E ...... or breast cancer therapeutics.

@ast

Stapled BIG3 helical peptide E ...... or breast cancer therapeutics.

@en

prefLabel

Stapled BIG3 helical peptide E ...... or breast cancer therapeutics.

@ast

Stapled BIG3 helical peptide E ...... or breast cancer therapeutics.

@en

P1433

Q33687329-5FE743B6-C3A2-4F9A-9125-EEBD151542E2

P1476

Q33687329-16F60CB6-758F-41D9-8551-45F75998F24D

P2093

Q33687329-496D9FBE-624A-4340-977D-77DC2AC400A4

Q33687329-5B0E189B-E8C9-449F-B0CD-91CB57EADD06

Q33687329-6E8044EE-7490-4863-89E4-B1C6ED68C12F

Q33687329-90EDF5BD-FF95-4366-A6AD-E917C7213598

Q33687329-A6C849D8-F21A-4037-BD1F-6F5A8F72AD61

Q33687329-B1E64036-9905-422D-8E1C-E9F15A768C71

Q33687329-DB168389-C275-4A26-A7B2-744EEC7CD31B

Q33687329-F54D8FD5-8CC8-4DAD-B3EB-C1A1BCA545F2

Q33687329-F7B70573-7599-4217-8817-8638B6B2A68F

P2860

Q33687329-232E0843-DA02-438E-BDB6-AE1B663396B2

Q33687329-2F5F9F5C-54AC-449E-9DFB-B8EA170DA011

Q33687329-35FE2EF9-C360-4F48-9C7D-BB389AB2F378

Q33687329-3BEC1F39-6974-455D-BDBA-3C7872486AA6

Q33687329-5503A947-1B33-4627-8134-A8A80B1EC736

Q33687329-553423C8-EA95-4F0D-980E-51C2A6312296

Q33687329-6B2D6A8B-1AEE-4731-B93D-6D968656A002

Q33687329-707EBE6E-0B3A-47C3-9ED2-4A775DD642E6

Q33687329-7A29A476-4C6A-4447-8CC4-CDADB465D352

Q33687329-7A59806E-A0E0-435C-9CCD-4664D316E736

P2888

Q33687329-0C9DF9A8-0887-4AC5-A75C-105F82B7664B

P304

Q33687329-7CB461B2-8F44-4B99-8EA5-96BEE02D779A

P31

Q33687329-17314DCE-F2A3-4F43-9A5A-D2E3E535864E

P356

Q33687329-52BE3B68-3C64-485E-A8BB-CD546F67BBB9

P407

Q33687329-7C319332-B6E2-4E61-9FAA-F3664061CDC2

P433

Q33687329-E4786B4E-4774-44C4-BADD-2FBC9AF639BE

P478

Q33687329-3390AD4C-E0CE-47E3-8861-CE2C2A5611E4

P50

Q33687329-D3BACC12-4FDB-45CA-AB80-FD818EF36BCC

Q33687329-EA3F3862-C13B-4F48-94EA-629A9CA4FFAD

P577

Q33687329-89EF888A-E20F-4B93-B7A0-F544B53BAF6D

P6179

Q33687329-54809552-0505-4C5A-BB2C-DF64897A2A85

P698

Q33687329-9EE43E5A-E6A2-4934-9088-7BDF27B61F2C

P932

Q33687329-08C3F7BE-0664-42FB-9043-5129C33ABE70

P356

S41598-017-01951-6

P1433

Scientific Reports

P1476

Stapled BIG3 helical peptide E ...... or breast cancer therapeutics.

@en

P2093

Akira Otaka

http://www.w3.org/2001/XMLSchema#string

Junko Honda

http://www.w3.org/2001/XMLSchema#string

Keisuke Aihara

http://www.w3.org/2001/XMLSchema#string

Masato Komatsu

http://www.w3.org/2001/XMLSchema#string

Mitsunori Sasa

http://www.w3.org/2001/XMLSchema#string

Tetsuro Yoshimaru

http://www.w3.org/2001/XMLSchema#string

Toyomasa Katagiri

http://www.w3.org/2001/XMLSchema#string

Yasuo Miyoshi

http://www.w3.org/2001/XMLSchema#string

Yosuke Matsushita

http://www.w3.org/2001/XMLSchema#string

P2860

An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

Hydrocarbon-stapled peptides: principles, practice, and progress

Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis.

Cellular and molecular pharmacology of antiestrogen action and resistance.

Tamoxifen: a most unlikely pioneering medicine.

Mechanisms of tamoxifen resistance.

Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.

BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells.

P2888

s41598-017-01951-6

P304

1821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-01951-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Shinya Toyokuni

Yasumasa Okazaki

P577

2017-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085371181

http://www.w3.org/2001/XMLSchema#string

P698

28500289

http://www.w3.org/2001/XMLSchema#string

P932

5431889

http://www.w3.org/2001/XMLSchema#string